This inventor holds 2 USPTO granted patents. Top assignee: Emory University. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Enrico De Cera: Innovator in Antithrombotic Research
Introduction
Enrico De Cera, an esteemed inventor based in Ladue, MO, has made significant contributions to the field of biomedical research. With a total of two patents to his name, he has focused his work on developing innovative solutions aimed at improving human health.
Latest Patents
De Cera's latest patents revolve around novel antithrombotic thrombin variants. These innovations relate to variants of thrombin or its fragments that can proteolytically activate protein C while being largely devoid of fibrinogen cleavage activity. His inventions also encompass variant polypeptides that can be cleaved to yield active thrombin variants. Furthermore, the patents describe methods for inhibiting thrombus formation in both animals and humans by delivering these antithrombotic variants to the bloodstream. Additionally, these novel thrombin variants are utilized to assess the level of protein C activation in blood samples and to evaluate the thrombogenic potential of patients.
Career Highlights
Throughout his career, Enrico De Cera has been associated with Emory University, where he has been instrumental in advancing research in the area of antithrombotic therapies. His academic and practical contributions have significantly impacted the field, especially in the development of therapeutic strategies for thrombotic disorders.
Collaborations
Enrico collaborates with other prominent researchers, including Andras Gruber and Stephen R. Hanson. These professional relationships further enhance the innovative research environment at Emory University and contribute to the advancement of their collective knowledge in biomedical sciences.
Conclusion
With his focus on antithrombotic variants and their applications, Enrico De Cera is paving the way for new therapeutic options in the treatment of thrombotic conditions. His contributions reflect a commitment to improving patient outcomes and highlight the importance of continual innovation in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile